Hemagen Diagnostics, Inc.

HMGN · OTC
Analyze with AI
9/30/2012
6/30/2012
3/31/2012
12/31/2011
Operating Activities
Net Income$0$0$0$0
Dep. & Amort.$37$40$44$44
Deferred Tax$0$0$0$0
Stock-Based Comp.$12$12$12$12
Change in WC$53$76$66$92
Other Non-Cash-$153-$112-$238-$356
Operating Cash Flow-$51$17-$117-$208
Investing Activities
PP&E Inv.-$4-$16-$7-$65
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$35
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$4-$16-$7-$30
Financing Activities
Debt Repay.$0$82$175$50
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$82$175$50
Forex Effect$13-$63$17-$7
Net Chg. in Cash-$41$20$68-$195
Supplemental Information
Beg. Cash$107$87$19$214
End Cash$66$107$87$19
Free Cash Flow-$54$1-$124-$273